{"title":"Molecular Modeling of Brassicaceae Derivatives for Inhibiting\nLipoxygenases: A Promising Therapeutic Strategy","authors":"W. Soufi, H. Allali, F. B. Hacene, S. Ghalem","doi":"10.2174/0115701638269042231122064738","DOIUrl":null,"url":null,"abstract":"\n\nInflammation plays a crucial role in the body's defense mechanisms, but\nuncontrolled inflammation can lead to chronic and pathological conditions. This study aimed to\nidentify natural compounds as potential replacements for the synthetic drug Zileuton, known for its\nside effects.\n\n\n\nUtilizing the MOE and Molegro modeling methods, several molecules were evaluated, and\nthree compounds, namely 1-Isothiocyanatopent-4-en-2-ol, 7-Isothiocyanatohept-1-ene, and 5-\n(Isothiocyanatomethyl)-1,2,3-trimethoxybenzene, exhibited superior inhibitory properties. These\ncompounds consistently demonstrated low energy values, indicating high inhibition potency. Notably, 5-(Isothiocyanatomethyl)-1,2,3-trimethoxybenzene emerged as the most promising candidate\namong all tested compounds.\n\n\n\nThese findings provide valuable insights for the development of alternative anti-inflammatory agents. Further research is required to assess the efficacy and safety profiles of these compounds\nin clinical settings.\n\n\n\nThis study represents a significant advancement in the search for innovative therapeutic strategies to manage inflammation-related disorders.\n","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"50 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug discovery technologies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115701638269042231122064738","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Inflammation plays a crucial role in the body's defense mechanisms, but
uncontrolled inflammation can lead to chronic and pathological conditions. This study aimed to
identify natural compounds as potential replacements for the synthetic drug Zileuton, known for its
side effects.
Utilizing the MOE and Molegro modeling methods, several molecules were evaluated, and
three compounds, namely 1-Isothiocyanatopent-4-en-2-ol, 7-Isothiocyanatohept-1-ene, and 5-
(Isothiocyanatomethyl)-1,2,3-trimethoxybenzene, exhibited superior inhibitory properties. These
compounds consistently demonstrated low energy values, indicating high inhibition potency. Notably, 5-(Isothiocyanatomethyl)-1,2,3-trimethoxybenzene emerged as the most promising candidate
among all tested compounds.
These findings provide valuable insights for the development of alternative anti-inflammatory agents. Further research is required to assess the efficacy and safety profiles of these compounds
in clinical settings.
This study represents a significant advancement in the search for innovative therapeutic strategies to manage inflammation-related disorders.
期刊介绍:
Due to the plethora of new approaches being used in modern drug discovery by the pharmaceutical industry, Current Drug Discovery Technologies has been established to provide comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery. The journal is the forum for publishing both original research papers and reviews describing novel approaches and cutting edge technologies used in all stages of drug discovery. The journal addresses the multidimensional challenges of drug discovery science including integration issues of the drug discovery process.